Maxim Group Announces Strategic Promotions in Healthcare Research
May 23, 2017 12:04 pm UTC| Business
NEW YORK, May 23, 2017 -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm is proud to announced the enhancement of its Healthcare Equity Research practice with the...
Maxim Group Announces Strategic Promotions in Healthcare Research
May 23, 2017 12:04 pm UTC| Business
NEW YORK, May 23, 2017 -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm is proud to announced the enhancement of its Healthcare Equity Research practice with the...
Maxim Group Announces Strategic Promotions in Healthcare Research
May 23, 2017 12:04 pm UTC| Business
NEW YORK, May 23, 2017 -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm is proud to announced the enhancement of its Healthcare Equity Research practice with the...
G1 Therapeutics Announces Closing of Initial Public Offering
May 23, 2017 12:03 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., May 23, 2017 -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced the closing of its initial public offering of 7,781,564 shares of common stock at a...
G1 Therapeutics Announces Closing of Initial Public Offering
May 23, 2017 12:03 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., May 23, 2017 -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced the closing of its initial public offering of 7,781,564 shares of common stock at a...
G1 Therapeutics Announces Closing of Initial Public Offering
May 23, 2017 12:03 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., May 23, 2017 -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced the closing of its initial public offering of 7,781,564 shares of common stock at a...
G1 Therapeutics Announces Closing of Initial Public Offering
May 23, 2017 12:03 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., May 23, 2017 -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced the closing of its initial public offering of 7,781,564 shares of common stock at a...